BMS-986507
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986507, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]